JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tiziano De Giacomo
Giuseppe Mazzesi
Federico Venuta
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Giacomo, T.
Right arrow Articles by Coloni, G.F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by De Giacomo, T.
Right arrow Articles by Coloni, G.F.
Related Collections
Right arrow Mechanical Circulatory Assistance

J Thorac Cardiovasc Surg 2007;134:1364-1365
© 2007 The American Association for Thoracic Surgery


Brief Communication

Extended operation for recurrent thymic carcinoma presenting with intracaval growth and intracardiac extension

Tiziano De Giacomo, MD*, Giuseppe Mazzesi, MD, Federico Venuta, MD, G.F. Coloni, MD

Department of Thoracic Surgery, University of Rome "Sapienza," Policlinico Umberto I, Rome, Italy.

Received for publication March 28, 2007; revisions received May 3, 2007; accepted for publication May 14, 2007.

* Address for reprints: Tiziano De Giacomo, MD, University of Rome "Sapienza," Policlinico Umberto I, Viale del Policlinico 155, 00159 Rome, Italy. (Email: tiziano.degiacomo@tin.it).

The first 20% of the full text of this article appears below.

Thymic carcinoma is a relatively uncommon tumor that represents less than 1% of thymic malignancies. The prognosis is often poor, with a 5-year survival for all patients of between 31% and 50%.1Go At present, a multimodality approach including aggressive surgical resection, platinum-based combination chemotherapy, and radiotherapy seems the preferred therapeutic strategy. Overall recurrence rate is very high and vascular invasion is particularly associated with poor prognosis.2,3Go Only aggressive and complete resection yields long-term survival. We report the management of recurrent thymic carcinoma with extension into the right atrium, resulting from the progression of intracaval growth, 4 years after induction chemotherapy and successful total resection followed by chemoradiation treatment.

Clinical Summary

A 46-year-old man with sudden engorgement of neck veins, swelling of the face, and mild ocular myasthenia was admitted to our institution. Recurrence of thymic carcinoma was suspected inasmuch as the patient had undergone radical resection, with negative resection margins, of thymic carcinoma 4 years earlier, after induction chemotherapy. The patient received postoperative adjuvant therapy, including 6 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
F. Venuta and E. A. Rendina
Superior vena cava resection and reconstruction
Eur J Cardiothorac Surg, January 18, 2012; (2012) ezr266v1.
[Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
F. Venuta, M. Anile, D. Diso, D. Vitolo, E. A. Rendina, T. De Giacomo, F. Francioni, and G. F. Coloni
Thymoma and thymic carcinoma
Eur J Cardiothorac Surg, January 1, 2010; 37(1): 13 - 25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.